Target intelligence / Profile preview

Transmembrane protein 238-like (TMEM238L)

Target
TMEM238L
Molecular classification
Other (single-pass or multipass membrane protein, not a canonical transporter/receptor/channel/enzyme)
01

Overview

Transmembrane protein 238-like (TMEM238L) is a small, conserved membrane protein in humans, encoded by the TMEM238L (also known as FORCP or LINC00675) gene, located on chromosome 17. TMEM238L is predicted to have a role in apoptosis via the intrinsic pathway during endoplasmic reticulum stress and may inhibit cell proliferation, potentially influencing tumorigenicity[5][9]. Though classified as a transmembrane protein, it is not part of a well-described receptor, transporter, or enzyme family. Its gene and protein are expressed in various tissues, with higher levels in the digestive tract and variable but wide expression elsewhere[6]. Disease associations include increased expression in certain cancers and nonmalignant disease states (asthma, POEMS syndrome), and its methylation or expression may serve as a biomarker in some contexts[1]. There are no specific drugs or therapies known to target TMEM238L directly, and its molecular mechanisms remain incompletely elucidated.

Other names
FORCPLINC00675FOXA1-regulated conserved small proteinFOXA1-Regulated Conserved Small Proteinlong intergenic non-protein coding RNA 675putative transmembrane protein LOC100289255
02

Biological functions

Apoptosis (intrinsic apoptotic signaling in response to endoplasmic reticulum stress)Potential inhibition of cell proliferationMay have a role in tumorigenicity suppression
03

Disease associations

Cancer (specifically low invasive breast cancers)Bardet-Biedl Syndrome 2 (related gene/disease association)POEMS syndromeFemale-specific body weight phenotypes (developmental origin)Asthma (gene upregulation observed in airway disease states)
04

Biomarkers

DNA methylation of TMEM238L (as biomarker for BPA exposure and weight phenotypes in mice)Expression changes in certain cancers and asthma

Beyond the preview

Go deeper on Transmembrane protein 238-like (TMEM238L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 238-like (TMEM238L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call